Stelzer Laurie is Chief Financial Officer of Mirati Therapeutics Inc.
Person profile
Roles
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Spyre Therapeutics, Inc.
16 May 24
4
Spyre Therapeutics, Inc.
27 Nov 23
3
Spyre Therapeutics, Inc.
27 Nov 23
4
Mirati Therapeutics, Inc.
10 Aug 23
4
PMV Pharmaceuticals, Inc.
12 Jun 23
4
Mirati Therapeutics, Inc.
2 Jun 23
4
Mirati Therapeutics, Inc.
24 Jan 23
4
Surface Oncology, Inc.
10 Jun 22
4
PMV Pharmaceuticals, Inc.
6 Jun 22
4
Mirati Therapeutics, Inc.
3 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 May 24 | SYRE Spyre Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 39.29 | 11,323 | 444.88 k | 11,323 |
22 Nov 23 | SYRE Spyre Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 10.39 | 50,000 | 519.50 k | 50,000 |
9 Aug 23 | MRTX Mirati Therapeutics | Common Stock | Grant | Acquire A | No | No | 37 | 22,297 | 824.99 k | 102,312 |
8 Jun 23 | PMVP PMV Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 5.59 | 21,500 | 120.19 k | 21,500 |